Filing Details
- Accession Number:
- 0001209191-17-015298
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-28 16:28:25
- Reporting Period:
- 2017-02-27
- Filing Date:
- 2017-02-28
- Accepted Time:
- 2017-02-28 16:28:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1000228 | Henry Schein Inc | HSIC | Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) | 113136595 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1194359 | J Donald Kabat | C/O Henry Schein, Inc. 135 Duryea Road Melville NY 11747 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2017-02-27 | 7,540 | $51.23 | 10,729 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.01 Per Share | Disposition | 2017-02-27 | 4,334 | $173.62 | 6,395 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Stock Option Right to Buy | Disposition | 2017-02-27 | 7,540 | $0.00 | 7,540 | $51.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-03-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | 6,000 | Indirect | By Trustees |
Footnotes
- The price reflects a weighted average of sales made at prices ranging from $173.56 to $173.64 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.
- Represents shares held in a trust where Mr. Kabat and his wife are co-trustees of the trust for the benefit of Mr. Kabat's wife.
- Acquired pursuant to the Issuer's 1996 Non-Employee Director Stock Incentive Plan, as amended.
- The option vested in four equal installments on each of March 5, 2008, March 5, 2009, March 5, 2010 and March 5, 2011.
Billionaire Hedge Funds
